Ticker Scorecard - NKTX Basics Company: Nkarta, Inc. IPO Date: July 10, 2020 Sector: Healthcare Industry: Biotech Market Cap: $144.67M Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 4.05% Avg Daily Range (30 D): $0.07 | 3.16% Avg Daily Range (90 D): $0.10 | 3.53% Institutional Daily Volume Avg Daily Volume: .75M Avg Daily Volume (30 D): .94M Avg Daily Volume (90 D): 1.22M Trade Size Avg Trade Size (Sh.): 118 Avg Trade Size (Sh.) (30 D): 171 Avg Trade Size (Sh.) (90 D): 179 Institutional Trades Total Inst.Trades: 650 Avg Inst. Trade: $1.71M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $1.67M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.73M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.22M Avg Closing Volume: 108.88K     News Nov 26, 2024 @ 12:02 PM Nkarta to Participate in an Upcoming Investor Conf... Source: N/A Sep 3, 2024 @ 8:01 PM Nkarta to Participate in Upcoming Investor Confere... Source: N/A Aug 14, 2024 @ 4:37 PM Why Nkarta Stock Is Soaring Today Source: Keith Speights Jul 16, 2024 @ 10:02 AM Nkarta Announces Leadership Updates, Appoints Nadi... Source: N/A Jun 27, 2024 @ 10:00 AM Nkarta Initiates Clinical Trial of NKX019 in Lupus... Source: Nkarta, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.83 $-.39 $-.34 Diluted EPS $-1.83 $-.39 $-.34 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -110.61M $ -28.34M $ -24.99M Operating Income / Loss $ -128.46M $ -33.79M $ -30.72M Cost of Revenue $ $ $ Net Cash Flow $ 18.7M $ -63.44M $ -129.89M PE Ratio